Renaissance Technologies LLC Buys Shares of 254,100 GE HealthCare Technologies Inc. $GEHC

Renaissance Technologies LLC bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 254,100 shares of the company’s stock, valued at approximately $18,087,000.

Other hedge funds also recently made changes to their positions in the company. Banque Cantonale Vaudoise boosted its holdings in GE HealthCare Technologies by 16,539.1% in the first quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock valued at $1,849,000 after acquiring an additional 25,801 shares during the last quarter. Allstate Corp grew its holdings in shares of GE HealthCare Technologies by 100.3% during the 4th quarter. Allstate Corp now owns 32,688 shares of the company’s stock worth $2,681,000 after purchasing an additional 16,365 shares during the period. Perpetual Ltd acquired a new stake in GE HealthCare Technologies during the 4th quarter worth approximately $37,656,000. Herbst Group LLC purchased a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $2,276,000. Finally, Auto Owners Insurance Co raised its holdings in GE HealthCare Technologies by 9,525.4% in the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after buying an additional 33,629,559 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $69.94 on Friday. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a current ratio of 1.26, a quick ratio of 0.95 and a debt-to-equity ratio of 0.92. The company has a market capitalization of $31.82 billion, a price-to-earnings ratio of 16.04, a price-to-earnings-growth ratio of 1.96 and a beta of 0.72. The business has a 50 day simple moving average of $63.94 and a 200-day simple moving average of $70.57.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.09. The firm had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. GE HealthCare Technologies had a return on equity of 20.12% and a net margin of 9.33%.The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the business posted $1.06 earnings per share. As a group, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is 3.35%.

Key GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Strong second-quarter results: GE HealthCare reported adjusted earnings of $1.13 per share versus the $1.04 consensus estimate, while revenue reached approximately $5.3 billion, ahead of expectations and up roughly 5.8% year over year. GE HealthCare reports second quarter 2026 financial results
• Positive Sentiment: Orders and backlog reached records: Organic orders increased about 11%, and total backlog rose to $23.9 billion. Strong demand for imaging, diagnostics and healthcare infrastructure gives GEHC greater revenue visibility. GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refunds
• Positive Sentiment: Management outlook and analyst sentiment improved: Reports indicate GEHC raised its EPS guidance, while Wells Fargo lifted its price target from $75 to $85 with an overweight rating. BTIG also raised its target to $79 and maintained a buy rating. GE HealthCare raises EPS guidance and reports record backlog
• Neutral Sentiment: Trading activity intensified: GEHC experienced unusually high options volume, including increased call buying. This may reflect bullish positioning, but options activity can also increase short-term volatility rather than signal a lasting change in valuation. GE HealthCare Technologies sees unusually high options volume
• Negative Sentiment: Profit quality and margins remain concerns: A tariff refund and lower tax rate contributed to the earnings beat, while adjusted EBIT margin contracted. Patient Care Solutions revenue declined sharply and the unit posted negative EBIT; management is reviewing strategic alternatives, including a possible sale.
• Negative Sentiment: Securities-fraud investigations added headline risk: Several law firms announced investigations into possible federal securities-law violations and solicited affected investors. These announcements do not establish wrongdoing, but they can pressure sentiment and create potential legal costs or liability. Securities fraud investigation into GE HealthCare continues

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on GEHC. Jefferies Financial Group cut their target price on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Evercore reaffirmed an “outperform” rating and set a $84.00 price target on shares of GE HealthCare Technologies in a research report on Thursday. Zacks Research downgraded GE HealthCare Technologies from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 21st. Mizuho cut their price objective on GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. Finally, BNP Paribas Exane reduced their price objective on GE HealthCare Technologies from $95.00 to $88.00 in a research note on Friday, May 1st. Ten research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $77.45.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, Director Rodney F. Hochman acquired 1,618 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were purchased at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the purchase, the director directly owned 1,618 shares in the company, valued at $100,364.54. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Watkin Phoebe L. Yang bought 1,000 shares of the business’s stock in a transaction on Friday, May 8th. The stock was acquired at an average cost of $63.01 per share, for a total transaction of $63,010.00. Following the acquisition, the director directly owned 13,702 shares of the company’s stock, valued at $863,363.02. The trade was a 7.87% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have acquired 12,618 shares of company stock worth $805,175. 0.36% of the stock is currently owned by insiders.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.